Recently, hypermorphic somatic phosphatidylinositol-4,5-bisphosphate 3-kinase and catalytic subunit alpha (PIK3CA) mutations have been found in various patients with malformative/overgrowth syndromes [83]. This evidence concerns the gene PIK3CA and overgrowth syndrome.